StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
FCL.NS$42.36+3.60%
Fair $42.36+0.0%

FCL.NS

Fineotex Chemical Limited

Basic Materials / Specialty ChemicalsNSE

$42.36

+1.47 (+3.60%)

Fairly Valued+0.0%Fair Value $42.36Fund rank 27/100 · Data gapFallback financials|
SA 59/C
F-Score: 2/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 33% · confianza 20%

FCF escenarios

weak_data · normalized FCF $17.6M · quality 47.0/100

Data gap 27/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 20/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

59/100

C

Piotroski

2/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists.
Thesis & Journal · FCL.NSLocal privado en este navegador · Fineotex Chemical Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$49.3B

P/E

38.9x

↑

EV/EBITDA

29.2x

↑

ROE

12.3%

↑

Gross Margin

33.0%

↑

Debt/Equity

0.01

↓
52-Week Range$42
$19$43

TradingView lightweight chart

FCL.NS price, volumen y niveles de valoración

Último $42.36Periodo +1621.6%
Fair value: $42.36

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2023–2026 · 3 años de histórico normalizado

Revenue CAGR

+14.4%

FCF CAGR

—

FCF margin

-6.3%

FCF / Net income

-0.44x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $7.72B · net income $1.09B · FCF $-483.7M

2023-FY → 2026-FY

Gross margin

33.0%-0.9% pts

Operating margin

15.7%-5.4% pts

Net margin

14.1%-3.0% pts

FCF margin

-6.3%-23.3% pts
MetricTTM
2026
2025
2024
2023
Income Statement
Revenue$7.72B$7.72B$5.33B$5.68B$5.16B
Net Income$1.09B$1.09B$1.08B$1.20B$883.2M
EBITDA$1.68B$1.68B$1.52B$1.64B$1.19B
EPS——0.9610.827.97
Gross Margin33.0%33.0%38.6%38.2%33.9%
Operating Margin15.7%15.7%22.1%25.1%21.1%
Net Margin14.1%14.1%20.3%21.1%17.1%
Balance Sheet
Debt/Equity0.010.010.000.010.02
Current Ratio2.802.80———
Cash Flow
Free Cash Flow$-483.7M$-483.7M$17.6M$491.4M$878.4M
Returns
ROE12.3%12.3%14.8%26.8%25.3%
Valuation
P/E38.8638.8623.943.622.97
EV/EBITDA29.2229.2216.902.541.94
P/B5.595.593.540.970.75
Growth & Yield
Revenue Growth44.8%44.8%-6.0%10.1%—
EPS Growth——-91.1%35.8%—
Dividend Yield0.4%0.4%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +75.8%

Total return

+75.8%

Start / end P/E

n/dx → n/dx

EPS bridge

0.96 → n/d

Residual

+75.4%

EPS growthn/d
Multiple reratingn/d
Dividend+0.4%
Residual / FX / buybacks / cross-term+75.4%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.